Consensus statements. Consensus statements.

Primary food allergy
Children between 4 and 17 years of age with a confirmed diagnosis of systemic peanut allergy should be offered oral immunotherapy with an approved preparation, taking into account an individual benefit-risk assessment.	Strong consensus
Pollen-associated food allergy
Pollen-associated food allergy may improve with subcutaneous or sublingual immunotherapy with pollen allergens. Such treatment may be considered only if there is a concurrent indication for treatment of pollen-related respiratory symptoms.	Strong consensus
In pollen-associated food allergy, oral immunotherapy with food allergen sources should only be used in the context of controlled trials.	Strong consensus